We recently reported that Swedish VH3-21-using chronic lymphocytic leukemia (CLL) patients showed restricted immunoglobulin gene features and poor prognosis despite VH mutation status. To investigate this further, we analyzed the VH and VL gene rearrangements in 90 VH3-21+ patients from Sweden, Germany, Italy, United States, Finland, and Australia and correlated these data with survival and other prognostic markers. Sixty-three percent exhibited mutated VH genes and 37% unmutated VH genes. Fifty (56%) patients displayed a short and homologous heavy-chain CDR3, many of these with the amino acid motif DANGMDV. Also, a highly biased V2-14 use was evident in 72% of patients with a restricted light-chain CDR3, QVWDS(S/G)SDHPWV. Combined restricted heavy- and light-chain CDR3s were found in patients from all included countries. Although VH3-21+ CLLs have a remarkably predominant expression, analyses of kappa deleting element indicated a conserved light-chain rearrangement order. The overall survival was poor in the VH3-21+ cohort (median survival, 88 months), with no significant difference in relation to mutation status or CDR3 homology. High ZAP-70 and CD38 expression was found in both mutated and unmutated VH3-21+ cases as well as a slight increase of 11q-aberrations. In summary, highly restricted B-cell receptors and worse outcome characterize VH3-21+ CLLs independent of geographic origin and mutation status.

Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status / Thorselius, M; Krober, A; Murray, F; Thunberg, U; Tobin, G; Buhler, A; Kienle, D; Albesiano, E; Maffei, Rossana; Dao Ung, Lp; Wiley, J; Vilpo, J; Laurell, A; Merup, M; Roos, G; Karlsson, K; Chiorazzi, N; Marasca, Roberto; Dohner, H; Stilgenbauer, S; Rosenquist, R.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 107:(2006), pp. 2889-2894.

Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

MAFFEI, Rossana;MARASCA, Roberto;
2006

Abstract

We recently reported that Swedish VH3-21-using chronic lymphocytic leukemia (CLL) patients showed restricted immunoglobulin gene features and poor prognosis despite VH mutation status. To investigate this further, we analyzed the VH and VL gene rearrangements in 90 VH3-21+ patients from Sweden, Germany, Italy, United States, Finland, and Australia and correlated these data with survival and other prognostic markers. Sixty-three percent exhibited mutated VH genes and 37% unmutated VH genes. Fifty (56%) patients displayed a short and homologous heavy-chain CDR3, many of these with the amino acid motif DANGMDV. Also, a highly biased V2-14 use was evident in 72% of patients with a restricted light-chain CDR3, QVWDS(S/G)SDHPWV. Combined restricted heavy- and light-chain CDR3s were found in patients from all included countries. Although VH3-21+ CLLs have a remarkably predominant expression, analyses of kappa deleting element indicated a conserved light-chain rearrangement order. The overall survival was poor in the VH3-21+ cohort (median survival, 88 months), with no significant difference in relation to mutation status or CDR3 homology. High ZAP-70 and CD38 expression was found in both mutated and unmutated VH3-21+ cases as well as a slight increase of 11q-aberrations. In summary, highly restricted B-cell receptors and worse outcome characterize VH3-21+ CLLs independent of geographic origin and mutation status.
107
2889
2894
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status / Thorselius, M; Krober, A; Murray, F; Thunberg, U; Tobin, G; Buhler, A; Kienle, D; Albesiano, E; Maffei, Rossana; Dao Ung, Lp; Wiley, J; Vilpo, J; Laurell, A; Merup, M; Roos, G; Karlsson, K; Chiorazzi, N; Marasca, Roberto; Dohner, H; Stilgenbauer, S; Rosenquist, R.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 107:(2006), pp. 2889-2894.
Thorselius, M; Krober, A; Murray, F; Thunberg, U; Tobin, G; Buhler, A; Kienle, D; Albesiano, E; Maffei, Rossana; Dao Ung, Lp; Wiley, J; Vilpo, J; Laurell, A; Merup, M; Roos, G; Karlsson, K; Chiorazzi, N; Marasca, Roberto; Dohner, H; Stilgenbauer, S; Rosenquist, R.
File in questo prodotto:
File Dimensione Formato  
Thorselius et al Blood 2006.pdf

non disponibili

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 229.5 kB
Formato Adobe PDF
229.5 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/613269
Citazioni
  • ???jsp.display-item.citation.pmc??? 41
  • Scopus 156
  • ???jsp.display-item.citation.isi??? 149
social impact